QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support

  • Posted by Emily Haynes
  • On January 7, 2019
  • 0 Comments
Enhancing QIAGEN’s industry-leading position with access to MarkerMine™ database and real-world evidence insights that provide insights for targeted therapy options Redwood City, California, and Hilden, Germany, January 7, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today it has entered into an agreement to acquire N-of-One, Inc., a privately-held U.S. molecular decision […]
Read More
BACK TO
TOP
LEARN
MORE